Drug Database
Back to search

Netherlands· NL-ba9335195a0b

Shingrix, poeder en suspensie voor suspensie voor injectie

A zoster, gereinigtes antigen product containing recombinant varicella zoster virus glycoproteine e-antigeen, registered in Netherlands by GlaxoSmithKline Biologicals S.A.. The same ATC class is registered in 10 of our 19 countries.

ATC J07BK03

Checked against CBG-MEB (Netherlands) on

Informational only — not a medical device.

SOURCE REGISTER · NLCBG-MEB (Netherlands)normalisedShingrix, poeder en suspensie voor su…ATCJ07BK03REGISTER NO.NL-ba9335195a0bPACKS LISTED1CHECKEDSeptember 29, 2026
Compare price across countriesPer daily dose · free accountAsk the assistant about recombinant varicella zoster virus glycoproteine e-antigeenAnswers with sources · free accountCheck interactionsSeverity free · mechanism on Growth

Where it is registered

Zoster, gereinigtes antigen is registered in 10 of 19 countries.

Countries holding a registration under ATC J07BK03 (zoster, gereinigtes antigen), each read from that country’s own register.

  • This record: Netherlands, from CBG-MEB (Netherlands)
  • 7 of them publish a price we can compare per daily dose
Search zoster, gereinigtes antigen products by name

Zoster, gereinigtes antigen · ATC J07BK03

10 / 19 countries

  • Belgiumprice
  • Czechiaprice
  • Denmark
  • Finlandprice
  • Icelandprice
  • Ireland
  • Netherlands
  • Norwayprice
  • Polandprice
  • Switzerlandprice
Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

The record

At a glance

CBG-MEB (Netherlands)
Active substance
RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEINE E-ANTIGEEN
Manufacturer
GlaxoSmithKline Biologicals S.A.
Country
Netherlands (NL)
ATC code
J07BK03
ATC class
Zoster, gereinigtes Antigen
Reimbursed
Not published by this register
Source register
CBG-MEB (Netherlands)
Last checked
September 29, 2026

Packs & prices · 1

  • cbg_meb_id
    EU/1/18/1272

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Same class

Other records under J07BK03

Zoster, gereinigtes antigen, as other registers publish it.

All zoster, gereinigtes antigen products

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload
GET /v1/drugs/e97cc804-bfb2-4781-bd34-a52850ebc06d
GET /v1/drugs/e97cc804-bfb2-4781-bd34-a52850ebc06d?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Poeder voor suspensie voor injectie",
  "route": "Intramusculair gebruik",
  "soort": null,
  "source": "cbg_meb",
  "smpc_url": "https://www.ema.europa.eu/en/documents/product-information/shingrix-epar-product-information_nl.pdf",
  "strength": null,
  "atc_label": "Zoster, purified antigen",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/cp120338",
  "excipients": [
    "3-O-DESACYL-4'-MONOFOSFORYLLIPIDE A",
    "CHOLESTEROL",
    "DIKALIUMWATERSTOFFOSFAAT 0-WATER (E 340)",
    "DINATRIUMWATERSTOFFOSFAAT 0-WATER (E 339)",
    "DIOLEOYLPHOSPHATIDYLCHOLINE",
    "KALIUMDIWATERSTOFFOSFAAT 0-WATER (E 340)",
    "NATRIUMCHLORIDE",
    "NATRIUMDIWATERSTOFFOSFAAT 2-WATER (E 339)",
    "POLYSORBAAT 80 (E 433)",
    "QS-21",
    "SACCHAROSE",
    "WATER VOOR INJECTIE"
  ],
  "substances": [
    "RECOMBINANT VARICELLA ZOSTER VIRUS GLYCOPROTEINE E-ANTIGEEN"
  ],
  "leaflet_url": null,
  "authorised_at": "2018/03/21",
  "procedure_number": "EMEA/H/C/004336",
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "EU/1/18/1272",
  "additional_monitoring": "N"
}
API referenceMCP serverPlans

See everything about zoster, gereinigtes antigen.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it freeOpen in the console